T HE RECOMMENDATIONS OF the American Thyroid Association (ATA) for iodine nutrition during pregnancy have been reviewed by the ATA's Public Affairs Committee in this issue of Thyroid (1) . The members of this committee are highly distinguished thyroidologists whose extensive experience brought together can only be equaled by the length of their individual professional careers (incidentally, I feel no longer that young myself!).
What have they done?
• They reviewed the different sources of dietary iodine in the population of the USA and Canada (salt, dairy products, vitamin/mineral preparations, etc.).
• They delineated the recommended daily iodine intake for non-pregnant (and non-lactating) adults and infants: 150 g of iodine/d for adults; 110 g of iodine/d for 0-6 month olds and 130 g of iodine/d for 7-12 month olds.
• They reviewed the recommended iodine intake for pregnant and lactating women. 
What are their conclusions for the general population?
• America's diet appears to be generally sufficient in overall iodine, although highly variable from food to food, and even among foods within the same category (dairy products, for instance).
• There are likely to be some outliers where iodine intake may be insufficient for some people and potentially excessive for others. One of the weaknesses of the NHANES surveys is that their design (with total anonymity) did not allow to pinpoint the geographical regions or socio-economic sections of North America where these 'outliers' may be more prevalent.
• The current data do not lead to a recommendation of iodine fortification in the diet for the population as a whole.
What are their main recommendations for the specific cases of pregnant and lactating women?
• To encourage manufacturers to include 150 g of iodine in all vitamin/mineral preparations labeled for use during pregnancy and lactation.
• To continue monitoring iodine nutrition in the US population, including larger sampling of pregnant women.
• To encourage continuing studies of nutritional sources of iodine for the US population by the FDA and the USDA.
• The committee came to the conclusion that until additional physiologic outcome data become available, supplementation of pregnant and lactating women with 150 g of iodine per day is in keeping with the current international recommendations and appears safe.
To evaluate the adequacy of iodine nutrition in a population, the best single parameter is provided by measurements of urinary iodine excretion levels (UIE) in a representative sampling of the population. However, although UIE is highly useful for public health estimations of iodine intake in a population, UIE alone is not a valid diagnostic criterion in individuals. To assess the adequacy (i.e., the long term sufficiency) of iodine nutrition in an individual, the best single parameter would be to estimate the amount of iodine stored within the thyroid gland, corresponding to ϳ10-20 mg of stable iodine. This parameter is, however, not measurable in practice. Therefore in a given pregnant woman, the best surrogate is to evaluate those thyroid parameters that have been shown to be sensitively altered when a pregnancy takes place in iodine-deficient women. Iodine restriction during pregnancy results in a significant lowering in serum free T 4 as well as a rise in serum TSH, a progressive increase in serum TG, an elevation of the total molar T 3 / T 4 ratio, and finally an increase in thyroid volume that may lead to goiter formation in both the mother and fetus (2) . During pregnancy, several physiologic changes take place in maternal thyroid economy which, together, lead to an increase in thyroid hormone production of ϳ50% above the preconception baseline hormone production. In order to achieve the necessary increment in thyroid hormone production which begins already in early gestation and is maintained throughout, the iodine intake needs to be increased during pregnancy (3). The Recommended Nutrient Intake (RNI) for iodine during pregnancy has recently been re-evaluated by an international expert committee under the auspices of the World Health Organization. The consensus reached by the panel was that the RNI for iodine during pregnancy should range between 200-300 g/day, with an average of 250 g/day. During breast-feeding, the physiology of thyroid hormone production and urinary iodine excretion returns to normal but iodine is efficiently concentrated by the mammary gland to be excreted in breast milk. Since breast milk provides approximately 100 g of iodine per day to the infant, it was also recommended that the breast-feeding mother should continue to take 250 g/day of iodine (4) .
For the implementation of iodine fortification during pregnancy, several epidemiological situations must be distinguished. In countries with a longstanding and well-established universal salt iodization (USI) program, pregnancies are not at risk of having iodine deficiency. Therefore, no systematic dietary fortification needs to be organized in these populations. It can however be recommended individually to pregnant women to use vitamin/mineral tablets specifically prepared for the needs of pregnancy and containing iodine supplements, since it has been shown that, even in such apparently satisfactory iodine intake conditions, a fraction of pregnant women may still have an insufficient dietary iodine intake. In countries without an efficient USI program, or an established USI program where the coverage is known to be only recent and/or partial, complementary approaches are required to reach the RNI for iodine. Such approaches include the use of iodine supplements in the form of potassium iodide (100-200 g/day) or the inclusion of KI (125-150 g/day) in vitamin/mineral preparations specifically manufactured for pregnancy requirements. Finally in areas with severe iodine deficiency and generally no accessible USI program and difficult socioeconomic conditions, it is recommended to administer iodized oil orally as early during gestation as possible.
The overall purpose of editing "recommendations" is debatable. Some would argue that recommendations tend to set obligations and thereby block the freedom of medical practice, and also reject novel approaches that wouldn't fit with the established dogma. Others would argue that, on the contrary, recommendations are an extremely useful tool because they help broadly set the scene of a medical issue and also provide helpful guidelines to care providers. Recommendations present an intrinsic difficulty, similar (conceptually, at least) to what can be observed in the field of economy when confronting macro-economic and microeconomic resources. For instance, a given country may have a good foreign trade exchange balance as well as a diminishing public internal debt (two obvious elements of macroeconomic success) and, nevertheless, face a high rate of unemployment among the young and low earnings for retirees (two obvious elements of a not-so-sound micro-economic situation). Similarly in medicine, there is a difficulty in extrapolating public health data (i.e., iodine excretion levels in a population) to the care of a single individual (i.e., the amount of iodine that a healthy woman with a normal pregnancy should receive), especially in the context of pregnancy which is-and should remain-considered a physiologic and hopefully joyful event. There is no easy way to bridge this gap. Thus, the efforts of the scientific community ought to base recommendations on the best available evidence-based information, processed by known experts in the field, who can then propose guidelines that are acceptable by all, until new evidence is obtained to modify our views. This is the challenge the ATA's Public Affairs committee succeeded in doing.
